Stock Information
4D Molecular Therapeutics Inc (FDMT)
Ticker Symbol: FDMT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $541.64 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -2.5478
Revenue (TTM): $1.33 M
Dividend Yield: N/A%
ROE: -31.75%
Latest News
-
4D Molecular Therapeutics (NASDAQ:FDMT) Q1 2026: Revenue Miss and Wider Losses Overshadow Phase 3 Progress
Thu, May 7, 2026 11:27 PM
-
4D Molecular Therapeutics Files Prospectus To Offer And Sell Up To $400M Of Securities In Multiple Offerings
Thu, May 7, 2026 5:53 PM
-
4D Molecular Therapeutics Q1 EPS $(1.01) Misses $(0.99) Estimate, Sales $3.047M Miss $5.167M Estimate
Thu, May 7, 2026 4:34 PM
-
4DMT to Participate in Upcoming Investor Conferences
Mon, May 4, 2026 8:02 AM
Key Financials
Financial data not available
